Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or With Dexamethasone in Relapsed and Refractory Multiple Myeloma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-0469
Full Text
Open PDFAbstract
Available in full text
Date
June 8, 2010
Authors
Publisher
American Association for Cancer Research (AACR)